Omeclamox Oral Tablet 500-500-20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Omeclamox: Oral tablet (500-500-20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15283.JPG
Omeclamox-Pak
Pernix Therapeutics, LLC Formerly Zyber Pharmaceutical Inc
Pill Identification: 54 312,R 158 OMEPRAZOLE 20 mg,WC 731 WC 731 

What is this Medicine?

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE (a mox i SIL in; kla RITH roe mye sin; oh ME pra zol) is a combination of three medicines used to treat ulcers associated with a bacterial infection.

CVS Pharmacy Patient Statistics for Omeclamox: Oral tablet(500-500-20mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Omeclamox-Pak

NDC: 652240707
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Helicobacter Pylori (H. Pylori) Eradication, Duodenal Ulcer

Sometimes used for but not FDA approved for the following conditions:
Gastric Ulcer

Storage Information
Protect from light
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Omeclamox-Pak
Drug Image file DrugItem_15283.JPG
Pernix Therapeutics, LLC Formerly Zyber Pharmaceutical Inc
Pill Identification: 54 312,R 158 OMEPRAZOLE 20 mg,WC 731 WC 731 
Shape: capsule,oblong
Color: gray,orange,peach,purple,white

Reported Side Effects for Omeclamox-Pak

Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Blurred Vision Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Stool Discoloration Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Cramps Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Testicular Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Tooth Discoloration Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Pus In Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Photosensitivity Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Red Spotted Rash Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Pancytopenia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Optic Atrophy Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eye Irritation Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Nightmares Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Gynecomastia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Urine Stones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hepatic Encephalopathy Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<1.1%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Torsade De Pointes Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Protein In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Mania Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low Blood Sodium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Dry Eyes Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.3%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
1.5%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.9%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
1.9-2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.0-5.2%*
Severity: MILD
Onset: EARLY
Gas Incidence:
2.7%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0-4.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
3.2%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Omeclamox-Pak

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Omeclamox-Pak(Clarithromycin)
Marijuana and Clarithromycin(Clarithromycin)
Clarithromycin can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Clarithromycin. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Minor Lifestyle Interaction
Grapefruit juice and Omeclamox-Pak(Clarithromycin)
Grapefruit juice and Clarithromycin(Clarithromycin)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Clarithromycin. There may be no interaction. Do not significantly change your grapefruit intake while taking Clarithromycin.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Omeclamox

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5